CD23 in Bhopal

CD23 is a substance present in B cell chronic lymphocytic leukemia or small lymphocytic lymphoma (B-CLL/SLL), two types of blood cancers causing overproduction of the mature lymphocytes or white blood cells (WBCs). In B-CLL, these abnormal lymphocytes accumulate in the blood and bone marrow, while in SLL, they accumulate in the lymph nodes. This test detects the expression of CD23 in cells, which helps pathologists identify and assess the presence, extent, and progression of this condition. CD23 testing is done for various reasons, including diagnosing B cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL), assessing the severity and progression of B-CLL/SLL, evaluating the effectiveness of treatment for B-CLL/SLL, and monitoring the response to therapy for B-CLL/SL. Your doctor might recommend CD23 testing if you have been diagnosed with B cell chronic lymphocytic leukemia or small lymphocytic lymphoma (B-CLL/SLL), show symptoms, or have risk factors for B-CLL/SLL, and if there is a need to evaluate the effectiveness or monitor the progress of treatment for B-CLL/SLL.